Naveris
Developer of a blood test technology designed to detect specific cancer subtypes and improve patient outcomes. The company's biomimetic technology replicates the morphological, signaling, and cell lin...
Valuation
$81.5M
Market implied
Share Price
N/A
Total Raised
$85.5M
Last Round
N/A